Medtronic, Inc. Starts “VITALITY,” A Post-Market Study of the Talent™ Abdominal Stent Graft

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), today reported the first enrollment in VITALITY1, the company’s post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms.